Rory Stuart (@RoryStuart15) profile picture

No financial advice - simply just musings & observations.

Wirral, UK
Joined December 2020
Photo by Rory Stuart (@RoryStuart15)Photo by Rory Stuart (@RoryStuart15)Photo by Rory Stuart (@RoryStuart15)Photo by Rory Stuart (@RoryStuart15)Photo by Rory Stuart (@RoryStuart15)Photo by Rory Stuart (@RoryStuart15)Photo by Rory Stuart (@RoryStuart15)Photo by Rory Stuart (@RoryStuart15)Photo by Rory Stuart (@RoryStuart15)Photo by Rory Stuart (@RoryStuart15)
Rory Stuart retweeted
Another outstanding performance from Chris on Thursday. #AVCT When you know you know and she definitely KNOWS! 1. FDA approved the removal of the life time allowance on a 50yr old chemo drug Doxorubicin in a Phase 1A safety trial last year. AVA6000 was the first drug ever to have achieved this in P1A….. 2. You then harness Exatecan aka ‘The Beast’ the most potent drug in its class where pharma failed to tame its toxicity for years. AVA6103 is that Precision drug now in clinical trials. 3. You state you can put almost any warhead on precision the delivery mechanism and have hundreds of options in the locker. 4. You compare your safety profile to a $5bn per year blockbuster drug Enhertu only months into your AVA6103 trial and blitz it! 5. You don’t sign up a dozen premier US trial sites if AVA6103 wasn’t working! Chris Coughlin @coughlin582 will be remembered as leading a small team of incredible talents who redefined what was possible and made it happen. Imagine you get diagnosed with this awful disease but there are new treatment options where the historical fear of awful side effects is no longer a fear as the standard of care is a Precision drug, where you can safely have more doses or higher doses giving you the best chance of survival at the same time. I believe the next few months will establish Avacta as the most disruptive company most have never heard of on the ADC/ oncology landscape. Most forget P1A patients are typically end of life who are prepared to aid science by their selfless acts to ensure others have a tomorrow. What Heroes! Thank you.
2
31
4
224
13,333
#AVCT a sensible take on LSE (for once!) It does feel like something is going on in the background, and perhaps the stabilisation of share price via a temporary suspension will prove to be a shrewd gambit Regardless; they've been placing brick after brick into the wall for time
4
2
36
4,144
I've been going back and forth for a long time now with chatGPT over #AVCT. I like playing that game. I pay £7 a month, and they sycophantically pretend I'm the smartest person in the room. It's a symbiotic relationship. Classic gold-digger behaviour; if you will... ANYWAY...
2
3
3,140
Obviously I fed in the x2 RNS info, and as best of a dictated AI transcription I could muster at x2 speed playback 🙄 of Christina & Ruairidh's #AVCT presentation... (What a mad spelling of my name by the way, but I like the fella, so we let it slide 💯) chatGPTs response?
1
3
2,494
"If I had to summarise today in one sentence, it would be this: Today didn't prove that Avacta will become a multi-billion-dollar platform company—but it did provide the strongest evidence yet that it has a realistic chance of becoming one." I'll take that. Partner time? #AVCT
2
2
36
2,800
#AVCT perhaps a little boring; but I actually really appreciate Christina's cadence in presentation. She's such an expert in disseminating complex information. You can tell that the mind blowing potential & outlook are now commonplace for her, and the rest of the team. Top tier.
1
24
1,461
FWIW; the £15.74k / 18,735 'sell' at 12:13:03today, was in fact, a buy. How do I know? Because it was mine. Important to know that trade visuals are just 'best guess' estimations based on the current bid/ask. I don't believe in an ulterior motive (it's just not perfect). #AVCT
Sitting bang on that 84p mark; even with that behemoth £210k / 250k volume sell. Anything sub-84p got bought up instantly. I am certainly looking forward to 2pm, but can't imagine we'll learn too much in the way of new info. It's clear that all deals will be on #AVCT's terms.
1
1
23
4,226
Sitting bang on that 84p mark; even with that behemoth £210k / 250k volume sell. Anything sub-84p got bought up instantly. I am certainly looking forward to 2pm, but can't imagine we'll learn too much in the way of new info. It's clear that all deals will be on #AVCT's terms.
#AVCT bang on the 20-day MA, looks to me like major support at ~84p, could be a run to 92p/93p shortly, then banging on the door of £1 in anticipation of next week's presentation. Gravy.
1
1
30
7,612
#AVCT bang on the 20-day MA, looks to me like major support at ~84p, could be a run to 92p/93p shortly, then banging on the door of £1 in anticipation of next week's presentation. Gravy.
3
1
27
9,964
Rory Stuart retweeted
8
19
2
163
11,439
#AVCT for a balanced view; Strand Hanson are specialists in licensing / partnership / M&A, as well as financing. But why would Avacta go to the effort of appointing a new NOMAD just for a raise, when Zeus (most notably @hughesy0707 / Richard Hughes) has delivered strongly here?
6
4
36
4,113
#avct @Ducatistealth all the subtlety of a hand grenade 🙄 I'll find a 50 pence piece down the back of the sofa for you, given how obsessed you are with it...
1
10
2,403
#VAST looking primed for a move back up
1
2
2
395
#OCDO minor support at ~172 Yikes!
148
#BME major support at ~152. Needs to hold there for recovery. As you'd expect, it is currently sitting at significantly below 20/50/200MA.
128
#MKA 46.67p on the ask for £10k, currently a little below the 50MA and day's high of 49p, first support looking around ~43p. Choppy day on the markets today. Opportunities for the brave.
547
#PTAL can anybody confidently find any technical support levels? It's looking high teens ~19p IMO One to watch.
4
1,184
#AVCT does anybody remember when the last TR-1 was? Seems mad that nothing has been logged over the last 12 months.
4
10
7,023